And the delays have costs. Had we landed Sanofi when we all expected, we'd probably already have $50 million per year revenue by now, at a minimum, and ramping from there. That wasn't Alan's fault but every delay results in tens of millions of dollars in lost (forever) revenue.
And here is another lost $20 million annually: http://ir.unilife.com/releasedetail.cfm?ReleaseID=727764. Why hasn't this approved drug gone anywhere for the past 23 months? While I have hopes and am keeping an "EYE" on Occuject, what's going out the door vs what's coming in does concern me. Timing (as in being on time) IS important for obvious reasons.
UNS Price at posting:
71.5¢ Sentiment: Hold Disclosure: Held